Literature DB >> 11445865

Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression.

P Behrens1, M Rothe, A Florin, A Wellmann, N Wernert.   

Abstract

The invasive potential of serous epithelial ovarian tumors is the main factor determining their biological behaviour. In contrast to invasive serous ovarian carcinomas serous borderline tumors generally present without stromal invasion and without or non-invading peritoneal implants. Little is known about the reasons underlying these differences. In the present study we found that two matrix-degrading metalloproteinases, collagenases 1 and 4 (MMPs 1 and 9), as well as the Ets-1 transcription factor are expressed at very low levels in serous benign cystadenomas, upregulated in the fibroblastic stroma, but not in the epithelium of borderline tumors and most strongly expressed in both stromal and epithelial tumor cells of serous invasive carcinomas. Since expression of Ets-1 and of MMPs 1 and 9 are topographically related, a transcriptional regulation of both proteases by Ets-1 is suggested. Upregulation of MMPs 1 and 9 within fibroblastic stromal cells of borderline tumors might be related to matrix remodelling and additional expression of both enzymes by the neoplastic cells of invasive carcinomas could then allow invasive propagation. The different expression patterns might supports the view, that no transition of serous borderline tumors into invasive carcinomas occurs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445865     DOI: 10.3892/ijmm.8.2.149

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  15 in total

1.  Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2.

Authors:  Chien-Min Chen; Yi-Hsien Hsieh; Jin-Ming Hwang; Hsun-Jin Jan; Shu-Ching Hsieh; Shin-Huey Lin; Chung-Yu Lai
Journal:  Tumour Biol       Date:  2014-12-20

2.  Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.

Authors:  Kazuyo Yasuda; Toshihiko Torigoe; Tasuku Mariya; Takuya Asano; Takafumi Kuroda; Junichi Matsuzaki; Kanae Ikeda; Makoto Yamauchi; Makoto Emori; Hiroko Asanuma; Tadashi Hasegawa; Tsuyoshi Saito; Yoshihiko Hirohashi; Noriyuki Sato
Journal:  Lab Invest       Date:  2014-10-20       Impact factor: 5.662

Review 3.  Ovarian cancer: involvement of the matrix metalloproteinases.

Authors:  Linah Al-Alem; Thomas E Curry
Journal:  Reproduction       Date:  2015-04-27       Impact factor: 3.906

4.  Licochalcone A inhibits the migration and invasion of human lung cancer cells via inactivation of the Akt signaling pathway with downregulation of MMP-1/-3 expression.

Authors:  Hung-Che Huang; Lo-Lin Tsai; Jen-Pi Tsai; Shu-Ching Hsieh; Shun-Fa Yang; Jung-Tsung Hsueh; Yi-Hsien Hsieh
Journal:  Tumour Biol       Date:  2014-08-23

5.  Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.

Authors:  Chia-Lung Tsai; Shih-Ming Jung; Lang-Ming Chi; Chi-Neu Tsai; Chiao-Yun Lin; Angel Chao; Yun-Shien Lee
Journal:  Aging (Albany NY)       Date:  2021-05-23       Impact factor: 5.682

6.  Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.

Authors:  Jean-Luc Brun; Annie Cortez; Bénédicte Lesieur; Serge Uzan; Roman Rouzier; Emile Daraï
Journal:  Oncol Rep       Date:  2011-12-22       Impact factor: 3.906

7.  Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.

Authors:  Nur Yucer; Rodney Ahdoot; Michael J Workman; Alexander H Laperle; Maria S Recouvreux; Kathleen Kurowski; Diana J Naboulsi; Victoria Liang; Ying Qu; Jasmine T Plummer; Simon A Gayther; Sandra Orsulic; Beth Y Karlan; Clive N Svendsen
Journal:  Cell Rep       Date:  2021-12-28       Impact factor: 9.423

Review 8.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

9.  MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.

Authors:  Liangqi Cao; Binhui Xie; Xuewei Yang; Huihong Liang; Xiaofeng Jiang; Dawei Zhang; Ping Xue; De Chen; Zili Shao
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 10.  The role of the tumor stroma in ovarian cancer.

Authors:  Ben Davidson; Claes G Trope; Reuven Reich
Journal:  Front Oncol       Date:  2014-05-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.